The tweet was deleted by the author.
But we saved everything 🙂.
Castle Biosciences took the stage at the Future Biotech Expo 2026, where Dr. Hillary Caruso presented new directions in precision healthcare.
Dr. Caruso, a leading scientist with Castle Biosciences, outlined the growing influence of advanced diagnostics, data applications, and emerging healthcare technologies. The session focused on integrating innovation and next-generation diagnostic tools to further personalize patient treatment. Industry attendees engaged on the potential for these technologies to reshape healthcare delivery. Details are being clarified.
View post on X Loading...
The company previously detailed its growth and expansion through Phoenix bioscience alliances, according to its COO Kristen Oelschlager. In 2024, Castle Biosciences also secured approval for a dual listing on Nasdaq Texas. These developments have contributed to the organization’s evolving footprint in the biotech sector.